JBP China

JBP China is the Chinese subsidiary of Japan Bio Products Co., Ltd., a global leader in the research and production of placental extract-based therapeutics. The company specializes in the development of pharmaceutical products, medical devices, and cosmeceuticals derived from human and animal placenta. Its flagship product, Laennec, is an ethical drug widely recognized for treating liver dysfunction and promoting tissue regeneration. JBP China focuses on the commercialization and regulatory management of these specialized biologics and high-precision medical devices, such as the JBP Nanoneedle, within the Chinese healthcare and aesthetic markets.